HK II interacts with VDAC1 to enable its localization to the mitochondria for glycolysis, and deficiency in sumoylation enhances the binding of HK II to VDAC1 on the outer mitochondrial membrane, thereby promoting glycolysis and facilitating cancer cell proliferation and drug resistance [68,69,70]. The gene discussed is HK2; the disease is cancer.